Literature DB >> 32314497

Clinicopathological differential diagnosis of IgG4-related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease.

Akira Satou1,2, Kenji Notohara2,3, Yoh Zen2,4, Shigeo Nakamura2,5, Tadashi Yoshino2,6, Kazuichi Okazaki2,7, Yasuharu Sato2,6,8.   

Abstract

IgG4-related disease (RD) is a relatively new entity, which was first proposed in 2001. Since then, clinical and pathological characteristics of the disease have been investigated. As IgG4-RD has been studied extensively, the diagnostic criteria for IgG4-RD of each organ and the comprehensive diagnostic criteria for IgG4-RD have also been developed. However, one of the biggest challenges in the field is distinguishing between IgG4-RD and mimickers, which show overlapping features with IgG4-RD. It is now known that some non-IgG4-RDs may meet the diagnostic criteria of IgG4-RD and can be misdiagnosed as IgG4-RD. However, accurate diagnosis is crucial, as the treatments for IgG4-RD and those for other diseases that may be misdiagnosed as IgG4-RD are different. This prompted us to create and propose comprehensive exclusion criteria for IgG4-RD. In this review, we have described the comprehensive exclusion criteria for IgG4-RD, with a historical overview of the disease. These exclusion criteria were recently created by the Research Program for Intractable Disease of the Ministry of Health, Labor, and Welfare of Japan, All Japan IgG4 team, to support correct and accurate diagnosis of IgG4-RD.
© 2020 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Keywords:  IgG4-related disease; criteria; diagnosis

Mesh:

Year:  2020        PMID: 32314497     DOI: 10.1111/pin.12932

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

Review 1.  Bibliometric analysis of IgG4-related disease research from 2003 to 2022 based on Web of Science Core Collection Databases.

Authors:  Zhijie Lv; Li Wu; Yan Lu; Shan Liu; Qiushuang Li
Journal:  Clin Rheumatol       Date:  2022-09-19       Impact factor: 3.650

2.  Acute Tubulointerstitial Nephritis in Rosai-Dorfman Disease Mimicking IgG4-related Disease.

Authors:  Satoshi Kurahashi; Naohiro Toda; Masaaki Fujita; Katsuya Tanigaki; Jun Takeoka; Hisako Hirashima; Eri Muso; Katsuhiro Io; Takaki Sakurai; Toshiyuki Komiya
Journal:  Intern Med       Date:  2021-09-18       Impact factor: 1.282

3.  Natural developing process of immunoglobulin G4-related sialadenitis after submandibular gland excision: a retrospective cohort study.

Authors:  Ke-Fu Zhang; Xia Hong; Wei Li; Yan Gao; Yan Chen; Yan-Yan Zhang; Jia-Zeng Su; Xin Peng; Guang-Yan Yu
Journal:  Clin Rheumatol       Date:  2021-07-18       Impact factor: 2.980

4.  Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.

Authors:  Asami Nishikori; Midori Filiz Nishimura; Yoshito Nishimura; Kenji Notohara; Akira Satou; Masafumi Moriyama; Seiji Nakamura; Yasuharu Sato
Journal:  Pathol Int       Date:  2021-11-11       Impact factor: 2.121

5.  Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease.

Authors:  Midori Filiz Nishimura; Takuro Igawa; Yuka Gion; Sakura Tomita; Dai Inoue; Akira Izumozaki; Yoshifumi Ubara; Yoshito Nishimura; Tadashi Yoshino; Yasuharu Sato
Journal:  J Pers Med       Date:  2020-12-10

Review 6.  Immunoglobulin G4-related Disease: A New Systemic Disease Emerging in Japan.

Authors:  Terumi Kamisawa
Journal:  JMA J       Date:  2021-12-15

7.  Historical and pathological overview of Castleman disease.

Authors:  Midori Filiz Nishimura; Yoshito Nishimura; Asami Nishikori; Tadashi Yoshino; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-04-27

8.  Immunoglobulin G4-related lymph node disease with an orbital mass mimicking Castleman disease: A case report.

Authors:  Feng-Yun Hao; Feng-Xia Yang; Hai-Yan Bian; Xia Zhao
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.